ILMN
NASDAQ · Life Sciences Tools & Services
Illumina Inc
$212.85
+4.85 (+2.33%)
ILMN News4 articles
Illumina's S&P 500 Debut Marred by Pre-Listing Dip Despite Record Volume
Illumina (ILMN) dropped 2.3% to $239.62 on Friday, even as trading volume surged 8.86x ahead of its S&P 500 inclusion. The stock joins the index Monday, but margin pressure and valuation remain concerns.
Illumina's S&P 500 Comeback Sparks $704M After-Hours Surge
Illumina's return to the S&P 500 triggered a 2.1% after-hours rally, adding $704 million in market cap, but the stock remains pricey versus analyst targets.
Danaher Shares Plunge 14% on Reduced Growth Forecast and Bioprocessing Gap
Danaher (DHR) stock dropped 14% after the company slashed its 2026 core-revenue growth forecast to 3%-4%, citing a bioprocessing order-to-revenue gap that overshadowed a quarterly earnings beat.
Thermo Fisher Files Multi-Tranche Bond Offering to Finance Clario Acquisition
Thermo Fisher Scientific shares edged higher Monday after filing a preliminary prospectus for a four-part senior notes offering to fund its planned Clario acquisition. The company reported consolidated debt of $39.38 billion as of December 31, 2025.